eMediWrite at COSDERMINDIA 2025: Empowering Pharma Brands with Strategy, Science & Storytelling

COSDERMINDIA 2025 once again proved to be a premier convergence of innovation, science, and marketing brilliance in dermatology. Held in Delhi, the event brought together leading dermatologists, pharma leaders, skincare innovators, and medical communication experts. This year, the eMediWrite team had the privilege of being invited to meet with key marketing heads, brand managers, and senior leadership…

Nanomedicine in Indian Pharma: Status, Challenges, and Future

What Is Nanomedicine? Nanomedicine involves using nanoscale materials typically under 100 nm for diagnosis, treatment, monitoring, and control of biological systems. It enables drug delivery with high precision, reduced toxicity, and enhanced bioavailability, offering solutions to many limitations of conventional therapeutics. Current Landscape in India India’s nanomedicine journey is gaining momentum, though still in its…

Biosimilars vs. Biologics: The Science Every Indian Pharma Team Must Understand

Biologics: A New Era of Therapeutics Biologics are complex, large-molecule drugs made using living cells. They include monoclonal antibodies, cytokines, and vaccines used to treat cancer, autoimmune diseases, and metabolic disorders. Unlike small-molecule drugs, biologics require advanced technology and stringent manufacturing controls. Examples like Herceptin (trastuzumab) for HER2-positive breast cancer and Humira (adalimumab) for autoimmune…

Pharmacogenomics in India: Is Personalized Medicine the Future?

The Promise of Precision Pharmacogenomics, the study of how genetic differences affect drug responses, is reshaping modern medicine. Tailoring treatments to an individual’s genetic makeup it offers more effective, safer therapies. In India, home to vast genetic diversity, pharmacogenomics could revolutionize healthcare. But challenges in access, awareness, and infrastructure remain. Genetic Diversity: Strength and Challenge…

What\’s New In This Financial Year for Pharma Brands: How They Are Getting Smarter with AI and Automation

  The pharma industry is undergoing an exciting transformation. This year, pharma brands aren’t just talking about AI and automation as futuristic buzzwords; they’re using these tools to create real, meaningful change for patients and healthcare providers. Helping Patients Before They Even Know They Need Help AI-powered predictive analytics are enabling brands to understand patient…

5 Tips That Ensure Your Medical Communication Agency Provides Quality Medico-Marketing Promotions on Time

Tight timelines, legal requirements, and competitive brand positioning are all integral to the job description of a pharmaceutical marketer. Product launches can be derailed and brand reputations harmed by delays in medical content or subpar deliverables. How can you ensure your medical communication agency doesn’t act as a roadblock, but rather as a growth partner? These…

Future Of Pharma Marketing

What Will the Future Hold for Pharma Marketing in 2025?

Pharmaceutical marketing is evolving rapidly, driven by technological advancements, shifting doctor preferences, and heightened regulatory scrutiny. As we step into 2025, here are the key trends shaping the future of pharmaceutical marketing. AI-Driven Personalization in Doctor Engagement* Artificial Intelligence (AI) is transforming the way pharmaceutical brands interact with healthcare professionals (HCPs). AI-powered tools analyse vast…